Shanghai GM Diagnosis

Shanghai GM Diagnosis Co., Ltd. is a leading third-party medical laboratory specializing in clinical molecular genetic testing and molecular pathology. Headquartered in Shanghai and operating as a subsidiary of Golden Meditech (and subsequently Global Cord Blood Corporation), the company provides high-end diagnostic services including newborn genetic screening, early cancer detection, and personalized medicine guidance. Its facility is accredited by the College of American Pathologists (CAP), ensuring international standards for its molecular diagnostic platforms. GM Diagnosis leverages advanced technologies such as next-generation sequencing and molecular biomarkers to support precision medicine initiatives across China. The company is a key player in the integration of diagnostic testing with healthcare services and cell therapy development.